ATE263239T1 - Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) - Google Patents

Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)

Info

Publication number
ATE263239T1
ATE263239T1 AT97910119T AT97910119T ATE263239T1 AT E263239 T1 ATE263239 T1 AT E263239T1 AT 97910119 T AT97910119 T AT 97910119T AT 97910119 T AT97910119 T AT 97910119T AT E263239 T1 ATE263239 T1 AT E263239T1
Authority
AT
Austria
Prior art keywords
kgf
growth factor
keratinocyte growth
products
variants
Prior art date
Application number
AT97910119T
Other languages
English (en)
Inventor
Linda Owens Narhi
Timothy D Osslund
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE263239T1 publication Critical patent/ATE263239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97910119T 1996-10-15 1997-10-15 Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) ATE263239T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2849396P 1996-10-15 1996-10-15
US3278196P 1996-12-06 1996-12-06
US3304696P 1996-12-11 1996-12-11
PCT/US1997/018607 WO1998016642A1 (en) 1996-10-15 1997-10-15 Keratinocyte growth factor-2 products

Publications (1)

Publication Number Publication Date
ATE263239T1 true ATE263239T1 (de) 2004-04-15

Family

ID=27363281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97910119T ATE263239T1 (de) 1996-10-15 1997-10-15 Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)

Country Status (11)

Country Link
EP (1) EP0935652B1 (de)
JP (2) JP2001506975A (de)
AT (1) ATE263239T1 (de)
AU (1) AU727678C (de)
CA (1) CA2269077C (de)
DE (2) DE19781038T1 (de)
DK (1) DK0935652T3 (de)
ES (1) ES2218666T3 (de)
GB (1) GB2322132B (de)
PT (1) PT935652E (de)
WO (1) WO1998016642A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077692A (en) * 1995-02-14 2000-06-20 Human Genome Sciences, Inc. Keratinocyte growth factor-2
US7232667B2 (en) 1995-02-14 2007-06-19 Human Genome Sciences, Inc. Keratinocyte growth factor-2 polynucleotides
US6693077B1 (en) 1995-02-14 2004-02-17 Human Genome Sciences, Inc. Keratinocyte growth factor-2
JP2000517174A (ja) * 1996-08-13 2000-12-26 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケラチノサイト増殖因子―２（ｋｇｆ―２または線維芽細胞増殖因子―１２、ｆｇｆ―１２）
SI0941110T1 (en) * 1996-10-15 2004-06-30 Amgen Inc. Uses of keratinocyte growth factor-2
AU1905799A (en) 1997-12-22 1999-07-12 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6869927B1 (en) 1997-12-22 2005-03-22 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
CA2375829A1 (en) * 1999-06-02 2000-12-07 Human Genome Sciences, Inc. Keratinocyte growth factor-2 formulations
JP2003520572A (ja) * 1999-07-02 2003-07-08 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケラチノサイト増殖因子−２
WO2002094871A1 (en) * 2001-05-24 2002-11-28 Human Dna Technology Inc Novel keratinocyte growth factor-2 analogue in hair follicle
AU2002345603B2 (en) * 2001-06-07 2006-10-12 Skinmedica, Inc. Conditioned cell culture media and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434053T2 (de) * 1993-06-29 2006-02-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
JPH09509054A (ja) * 1994-02-01 1997-09-16 アメリカ合衆国 抗体部分および非抗体部分を含む融合タンパク質
PT785950E (pt) * 1994-10-13 2003-09-30 Amgen Inc Analogos do factor de crescimento de queratinocitos
KR100278597B1 (ko) * 1994-10-13 2001-01-15 스티븐 엠. 오드리 케라티노사이트 성장 인자의 유사체, 이 유사체를 암호하는 핵산 및 그것의 제조방법
NZ282146A (en) * 1995-02-14 1999-10-28 Human Genome Sciences Inc Polypeptide and polynucleotides having kgf-2 activity
JP2000517174A (ja) * 1996-08-13 2000-12-26 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケラチノサイト増殖因子―２（ｋｇｆ―２または線維芽細胞増殖因子―１２、ｆｇｆ―１２）

Also Published As

Publication number Publication date
AU4757697A (en) 1998-05-11
DE69728415T2 (de) 2004-08-12
EP0935652A1 (de) 1999-08-18
ES2218666T3 (es) 2004-11-16
DK0935652T3 (da) 2004-07-26
EP0935652B1 (de) 2004-03-31
AU727678C (en) 2005-05-12
CA2269077A1 (en) 1998-04-23
AU727678B2 (en) 2000-12-21
DE19781038T1 (de) 1998-12-10
GB9811279D0 (en) 1998-07-22
JP2008283980A (ja) 2008-11-27
GB2322132B (en) 1999-09-22
JP2001506975A (ja) 2001-05-29
WO1998016642A1 (en) 1998-04-23
HK1022714A1 (en) 2000-08-18
GB2322132A (en) 1998-08-19
CA2269077C (en) 2004-04-06
PT935652E (pt) 2004-07-30
DE69728415D1 (de) 2004-05-06

Similar Documents

Publication Publication Date Title
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
DE69029657D1 (de) Menschliches cytokin, interleukin-9
IL117425A0 (en) Receptor activation by gas6
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE449850T1 (de) Mutanten von flt3-l und ihre verwendungen
ATE263239T1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
BG101408A (bg) Аналози на кератиноцитния растежен фактор
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DK1082423T3 (da) Cyclin E2-gener og -proteiner
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69931759D1 (de) Methode zur erstellung von genexpressionsprofilen
PT977859E (pt) O factor neurotrofico nnt-1
ATE338768T1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
ES2117717T3 (es) Tratamiento de tumores con factores neurotroficos e inhibidores de la proliferacion celular.
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE389014T1 (de) Phosphorylierte glyoxalase i und deren verwendung
SE9604439D0 (sv) New receptor
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DK143984D0 (da) Nitrogenkilde til organismer
MXPA04004262A (es) Delta-1-pirrolinas.
WO2000061750A3 (en) TYROSINE KINASE SUBSTRATE (Tks) PROTEINS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0935652

Country of ref document: EP

EEIH Change in the person of patent owner